Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings
- 30 November 2017
- journal article
- review article
- Published by Wiley in Vox Sanguinis
- Vol. 113 (1), 3-12
- https://doi.org/10.1111/vox.12620
Abstract
Transfusion-transmitted infection risk remains an enduring challenge to blood safety in Africa. A high background incidence and prevalence of the major transfusion-transmitted infections (TTIs), dependence on high-risk donors to meet demand, suboptimal testing and quality assurance collectively contribute to the increased risk. With few exceptions, donor testing is confined to serological evaluation of human immunodeficiency virus (HIV), hepatitis B and C (HBV and HCV) and syphilis. Barriers to implementation of broader molecular methods include cost, limited infrastructure and lack of technical expertise. Pathogen reduction (PR), a term used to describe a variety of methods (e.g. solvent detergent treatment or photochemical activation) that may be applied to blood following collection, offers the means to diminish the infectious potential of multiple pathogens simultaneously. This is effective against different classes of pathogen, including the major TTIs where laboratory screening is already implemented (e.g. HIV, HBV and HCV) as well pathogens that are widely endemic yet remain unaddressed (e.g. malaria, bacterial contamination). We sought to review the available and emerging PR techniques and their potential application to resource-constrained parts of Africa, focusing on the advantages and disadvantages of such technologies. PR has been slow to be adopted even in high-income countries, primarily given the high costs of use. Logistical considerations, particularly in low-resourced parts of Africa, also raise concerns about practicality. Nonetheless, PR offers a rational, innovative strategy to contend with TTIs; technologies in development may well present a viable complement or even alternative to targeted screening in the future.Keywords
This publication has 84 references indexed in Scilit:
- Photochemical Inactivation of Chikungunya Virus in Human Apheresis Platelet Components by Amotosalen and UVA LightThe American Journal of Tropical Medicine and Hygiene, 2013
- Hepatitis C virus (HCV) infection in Africa: a reviewPan African Medical Journal, 2013
- Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology systemTransfusion, 2012
- Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system – An updateTransfusion and Apheresis Science, 2012
- Blood Transfusion Safety in Africa: A Literature Review of Infectious Disease and Organizational ChallengesTransfusion Medicine Reviews, 2012
- The Use of Solvent/Detergent Treatment in Pathogen Reduction of PlasmaTransfusion Medicine and Hemotherapy, 2011
- Transfusion‐Transmitted Malaria in Countries Where Malaria Is Endemic: A Review of the Literature from Sub‐Saharan AfricaClinical Infectious Diseases, 2010
- Dose of Prophylactic Platelet Transfusions and Prevention of HemorrhageNew England Journal of Medicine, 2010
- TRANSFUSION COMPLICATIONS: Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospitalTransfusion, 2009
- A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh‐frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraTransfusion, 2006